VANCOUVER, November 11, 2019 /CNW/ — InMed Pharmaceuticals Inc. (“InMed” or “the Company”) (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids… Read More
VANCOUVER, BRITISH COLUMBIA–(November 7, 2019) – SignalChem Lifesciences Corp. (“SLC”), a clinical stage biotech company, has dosed its first patient in a Phase 1 clinical trial studying the safety and… Read More
Augurex is pleased to announce the launch of JOINTstat (14-3-3ƞ) testing services through Dynacare, one of Canada’s largest and most established health solution companies with a dedicated mission to support… Read More
VANCOUVER, BC – Today, LifeSciences BC, a non-profit, industry association which supports and represents the life sciences community of British Columbia, and Lumira Ventures, a leading North American healthcare venture… Read More
Conference Call and Webcast Scheduled Today at 8:45 AM ET WARMINSTER, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a Hepatitis B Virus (HBV) therapeutic solutions company, today reports its… Read More
